Bendamax IV Infusion

About Bendamax 25 mg/vial IV Infusion

The iv infusion Bendamax contains Bendamustine and is made by Beacon Pharmaceuticals Ltd. Efficacy relative to first line therapies other than chlorambucil has not been established.

What is Bendamax 25 mg/vial IV Infusion?

Bendamax comes as a iv infusion with 25 mg/vial of Bendamustine, from Beacon Pharmaceuticals Ltd. Bendamustine is a bifunctional mechlorethamine derivative capable of forming electrophilic alkyl groups that covalently bond to other molecules. Non-Hodgkin Lymphoma (NHL) : Bendamustineis indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. The doctor decides the dose and course.

Uses of Bendamax

Efficacy relative to first line therapies other than chlorambucil has not been established. Read more Chronic Lymphocytic Leukemia (CLL) : Bendamustine is indicated for the treatment of patients with chronic lymphocytic leukemia. Your doctor will decide if it is suitable for you.

How to use Bendamax

If you are unsure how to take it, ask your doctor or pharmacist. If you miss a dose, ask your doctor or pharmacist what to do. Do not change the dose or stop early without asking your doctor.

Side effects of Bendamax

Malignant and pre-malignant disease; pyrexia, nausea, vomiting, cough, headache, fatigue, diarrhoea, constipation, anorexia, wt decrease, rash, stomatitis, lymphopenia, anaemia, thrombocytopenia, leucopenia, neutropenia. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Mild to moderate hepatic and renal impairment. Anaphylaxis and anaphylactoid reactions); jaundice, severe bone marrow suppression, low leukocyte or platelet count. Patient with history of hypersensitivity (e.g. Tell your doctor about all the other medicines you take.

Frequently asked questions

What does Bendamax treat?

Efficacy relative to first line therapies other than chlorambucil has not been established. Read more Chronic Lymphocytic Leukemia (CLL) : Bendamustine is indicated for the treatment of patients with chronic lymphocytic leukemia.

How should I take Bendamax?

If you are unsure how to take it, ask your doctor or pharmacist. If you miss a dose, ask your doctor or pharmacist what to do.

What are the side effects of Bendamax?

Malignant and pre-malignant disease; pyrexia, nausea, vomiting, cough, headache, fatigue, diarrhoea, constipation, anorexia, wt decrease, rash, stomatitis, lymphopenia, anaemia, thrombocytopenia, leucopenia, neutropenia. Tell your doctor if any side effect bothers you or does not go away.

How much does Bendamax cost in Bangladesh?

The listed price is ৳ 1200.00.

Indications

Chronic Lymphocytic Leukemia (CLL): Bendamustine is indicated for the treatment of patients with chronic lymphocytic leukemia. Efficacy relative to first line therapies other than chlorambucil has not been established.

Non-Hodgkin Lymphoma (NHL): Bendamustineis ... Read moreChronic Lymphocytic Leukemia (CLL): Bendamustine is indicated for the treatment of patients with chronic lymphocytic leukemia. Efficacy relative to first line therapies other than chlorambucil has not been established.

Non-Hodgkin Lymphoma (NHL): Bendamustineis indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

Also indicated in Multiple myeloma.

Pharmacology

Bendamustine is a bifunctional mechlorethamine derivative capable of forming electrophilic alkyl groups that covalently bond to other molecules. Through this function as an alkylating agent, bendamustine causes intra- and inter-strand crosslinks between DNA bases resulting in cell death. It is active against both active and quiescent cells, although the exact mechanism of action is unknown.

Dosage & Administration

Chronic lymphocytic leukaemia: 100 mg/m2 infused over 30-60 min on days 1 and 2 of a 28-day cycle for up to 6 cycles. For severe haematological or non-haematological toxicity: Reduce dose to 50 mg/m2 on days 1 and 2 of each cycle. If severe haematological toxicity recurs, further reduce dose to 25 mg/m2 on days 1 and 2 of each cycle. May consider dose re-escalation in subsequent cycles.

Multiple myeloma: 120-150 mg/m2 infused over 30-60 min on days 1 and 2 of a 28-day cycle. IV or oral prednisone may be given at a dose of 60 mg/m2 on days 1-4 of the cycle.

Non-Hodgkin's lymphoma: 120 mg/m2 infused over 30-60 min on days 1 and 2 of a 21-day cycle for up to 8 cycles. For severe haematological or non-haematological toxicity: Reduced to 90 mg/m2 on days 1 and 2 of each cycle. If severe toxicity recurs, further reduce dose to 60 mg/m2 on days 1 and 2 of each cycle.

Interaction

May increase plasma levels with CYP1A2 inhibitors (e.g. ciprofloxacin, fluvoxamine). May reduce plasma levels with CYP1A2 inducers (e.g. omeprazole and tobacco smoking).

Contraindications

Patient with history of hypersensitivity (e.g. anaphylaxis and anaphylactoid reactions); jaundice, severe bone marrow suppression, low leukocyte or platelet count. Severe hepatic impairment. Major surgery <30 days prior to treatment.

Side Effects

Malignant and pre-malignant disease; pyrexia, nausea, vomiting, cough, headache, fatigue, diarrhoea, constipation, anorexia, wt decrease, rash, stomatitis, lymphopenia, anaemia, thrombocytopenia, leucopenia, neutropenia.

Pregnancy & Lactation

Pregnancy category D. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).

Precautions & Warnings

Mild to moderate hepatic and renal impairment. Pregnancy and lactation.

Overdose Effects

Symptoms: Cardiotoxicity, thrombocytopenia.

Management: May perform bone marrow transplantation and transfusions to control haematological effects. It is dialysable to a small extent.

Storage Conditions

Store below 25° C, prior to reconstitution. Protect from light.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.